Qinghua Cui

InstitutionUniversity of Electronic Science and Technology of China
AddressChengdu
Sichuan
China
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 7 Covid-19 publications, with a maximum of 1 publications in May 2020 and July 2020 and October 2020 and February 2021 and April 2021 and May 2021 and August 2021
    All Publications
    Bar chart showing 150 publications over 18 distinct years, with a maximum of 25 publications in 2018
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Cui C, Huang C, Zhou W, Ji X, Zhang F, Wang L, Zhou Y, Cui Q. AGTR2, One Possible Novel Key Gene for the Entry of SARS-CoV-2 Into Human Cells. IEEE/ACM Trans Comput Biol Bioinform. 2021 Jul-Aug; 18(4):1230-1233. PMID: 32750889.
      Citations: 17     Fields:    Translation:HumansCells
    2. Chen Z, Du R, Galvan Achi JM, Rong L, Cui Q. SARS-CoV-2 cell entry and targeted antiviral development. Acta Pharm Sin B. 2021 Dec; 11(12):3879-3888. PMID: 34002130.
      Citations: 1     
    3. Du R, Cooper L, Chen Z, Lee H, Rong L, Cui Q. Discovery of chebulagic acid and punicalagin as novel allosteric inhibitors of SARS-CoV-2 3CLpro. Antiviral Res. 2021 06; 190:105075. PMID: 33872675.
      Citations: 6     Fields:    Translation:AnimalsCells
    4. Chen Z, Cui Q, Cooper L, Zhang P, Lee H, Chen Z, Wang Y, Liu X, Rong L, Du R. Ginkgolic acid and anacardic acid are specific covalent inhibitors of SARS-CoV-2 cysteine proteases. Cell Biosci. 2021 Feb 28; 11(1):45. PMID: 33640032.
      Citations: 7     
    5. Kang Q, Wang Y, Cui Q, Gong L, Yang Y, Jiang H, Rong L, Rong R, Du R. Screening for Anti-Influenza Actives of Prefractionated Traditional Chinese Medicines. Evid Based Complement Alternat Med. 2020; 2020:4979850. PMID: 33123207.
      Citations: 2     
    6. Wang Y, Anirudhan V, Du R, Cui Q, Rong L. RNA-dependent RNA polymerase of SARS-CoV-2 as a therapeutic target. J Med Virol. 2021 01; 93(1):300-310. PMID: 32633831.
      Citations: 23     Fields:    
    7. Ren X, Shao XX, Li XX, Jia XH, Song T, Zhou WY, Wang P, Li Y, Wang XL, Cui QH, Qiu PJ, Zhao YG, Li XB, Zhang FC, Li ZY, Zhong Y, Wang ZG, Fu XJ. Identifying potential treatments of COVID-19 from Traditional Chinese Medicine (TCM) by using a data-driven approach. J Ethnopharmacol. 2020 Aug 10; 258:112932. PMID: 32376368.
      Citations: 28     Fields:    Translation:HumansCellsPHPublic Health